Skip to main navigation menu Skip to main content Skip to site footer

Platelet-derived growth factors : from laboratory to hemato-oncological clinical application.

Factores de crecimiento derivados de plaquetas : del laboratorio a la aplicación clínica hemato-oncológica.




Section
Editorial

How to Cite
Platelet-derived growth factors : from laboratory to hemato-oncological clinical application.
Rev. colomb. hematol. oncol. [Internet]. 2016 Jun. 1 [cited 2024 Dec. 21];3(2):8-9. Disponible en: https://doi.org/10.51643/22562915.149

Dimensions
PlumX
Milton Lombana


    Article visits 88 | PDF visits 315


    1. Gimbrone MA Jr, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969;222(5188):33-6.
    2. Michelson A. Platelets. 3rd ed. Elsevier; 2012.
    3. Smadja DM, Bura A, Szymezak J, Blanchard A, Remones V, Azizi M, et al. Effect of clopidogrel on circulating biomarkers of angiogenesis and endothelial activation. J Cardiol. 2012;59(1):30-5.
    4. Etulain J, Fondevila C, Negrotto S, Schattner M. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br J Pharmacol. 2013;170(2):255-65.
    5. Nilsson J, Volk-Jovinge S, Svensson J, Landou C, De Faire U, Hamsten A. Association between high levels of growth factors in plasma and progression of coronary atherosclerosis. J Intern Med. 1992;232(5):397-404.
    6. Currie GA. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells. Br J Cancer. 1981;43(3):335-43.
    7. Liu C, Zhao W, Meng W, Zhao T, Chen Y, Ahokas RA, et al. Platelet-derived growth factor blockade on cardiac remodeling following infarction. Mol Cell Biochem. 2014;397(1-2):295-304.
    8. Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA, Sun Y. Plateletderived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol. 2011;51(5):830-8.
    9. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006;48(11):2315-23.
    10. Yu J, Ustach C, Kim HR. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol. 2003;36(1):49-59.
    11. Wang Y, Appiah-Kubi K, Wu M, Yao X, Qian H, Wu Y, et al. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer. Growth Factors. 2016;34(1-2):64-71.
    12. Appiah-Kubi K, Wang Y, Qian H, Wu M, Yao X, Wu Y, et al. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers. Tumour Biol. 2016;37(8):10053-66.
    13. Ehnman M, Östman A. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opin Investig Drugs. 2014;23(2):211-26.
    Sistema OJS 3.4.0.7 - Metabiblioteca |